In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d [0.03%]
在复杂性尿路感染中，头孢吡肟-泰万诺拉姆的治疗成功率高于亚胺培南，持续时间为19至23天
Bruno Granwehr
Bruno Granwehr
Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390:611-622. 38354140.
Randomized Controlled Trial
Annals of internal medicine. 2024 Jun;177(6):JC67. DOI:10.7326/ANNALS-24-00447-JC 2024
The Cost-Effectiveness of Prostate Cancer Screening That Incorporates Magnetic Resonance Imaging [0.03%]
基于磁共振成像的前列腺癌筛查的成本效益分析
Daniel D Joyce,Ruchika Talwar,Kelvin A Moses
Daniel D Joyce
In ischemic stroke, adding IV thrombolysis ≤2 h after symptom onset to thrombectomy was associated with benefit [0.03%]
在缺血性卒中中，在发病后2小时内加用静脉溶栓的桥接治疗较单用取栓疗效更佳
Ivy A Sebastian,Michael D Hill
Ivy A Sebastian
Kaesmacher J, Cavalcante F, Kappelhof M, et al; IRIS Collaborators. Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke: a meta-analysis. JAMA. 2024;331:764-777. 38324409.
Artificial Intelligence in the Provision of Health Care: An American College of Physicians Policy Position Paper [0.03%]
人工智能在医疗保健的提供中的应用——美国内科医学协会政策立场文件
Nadia Daneshvar,Deepti Pandita,Shari Erickson et al.
Nadia Daneshvar et al.
Internal medicine physicians are increasingly interacting with systems that implement artificial intelligence (AI) and machine learning (ML) technologies. Some physicians and health care systems are even developing their own AI models, both...
After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit [0.03%]
ACS置入支架后替格瑞洛单药治疗二期研究
Jia Ee Chia,Debabrata Mukherjee
Jia Ee Chia
Hong SJ, Lee SJ, Suh Y, et al; T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators. Stopping aspirin within 1 month after stenting for ticagrelor monotherapy ...
Randomized Controlled Trial
Annals of internal medicine. 2024 Jun;177(6):JC64. DOI:10.7326/ANNALS-24-00207-JC 2024
PREVENT equations predicted risk for incident CVD in adults aged 30 to 79 y [0.03%]
基于传统危险因素的动脉粥样硬化性心血管疾病预测方程式的建立与验证
Nkiru Osude,Christopher Granger
Nkiru Osude
Khan SS, Matsushita K, Sang Y, et al; Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association's PREV...
Use of Telehealth Among Medical Visits in the United States: Results From the 2021 Medical Expenditure Panel Survey [0.03%]
美国医疗支出面板调查中关于美国医疗访问中的远程医疗服务使用情况的结果报告
Sandra L Decker,William E Encinosa,Samuel H Zuvekas
Sandra L Decker
In adult tobacco smokers, adding e-cigarettes to standard smoking cessation counseling increased abstinence at 6 mo [0.03%]
在成人烟草烟民中，与常规的吸烟戒断咨询联合使用电子烟使得6个月后的戒断率提高
Peter S Millard
Peter S Millard
Auer R, Schoeni A, Humair JP, et al. Electronic nicotine-delivery systems for smoking cessation. N Engl J Med. 2024;390:601-610. 38354139.
Randomized Controlled Trial
Annals of internal medicine. 2024 Jun;177(6):JC70. DOI:10.7326/ANNALS-24-00229-JC 2024
In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y [0.03%]
在非酒精性脂肪肝患者中，Resmetirom治疗一年可改善NASH并减少纤维化
Maria Mironova,Averell H Sherker
Maria Mironova
Harrison SA, Bedossa P, Guy CD, et al. MAESTRO-NASH Investigators. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497-509. 38324483.
Randomized Controlled Trial
Annals of internal medicine. 2024 Jun;177(6):JC63. DOI:10.7326/ANNALS-24-00206-JC 2024
Christine Laine,Darilyn V Moyer,Amir Qaseem
Christine Laine